These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 19126028)

  • 1. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
    Jedlickova H; Bohmová J; Sirotkova A
    Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028
    [No Abstract]   [Full Text] [Related]  

  • 2. [Invasive disseminated aspergillosis in combined immunosuppressive therapy in systemic lupus erythematosus].
    Teuber G; Schwarting A; Mildenberger P; Schmidt-Brücken G; Moll R; Bornemann A; Wandel E; Wanitschke R; Meyer zum Büschenfelde KH
    Med Klin (Munich); 1996 Dec; 91(12):798-801. PubMed ID: 9082168
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
    Heras M; Saiz A; Fernández-Reyes MJ; Sánchez R; Zurita P; Urrego C
    Nefrologia; 2011; 31(2):231-3. PubMed ID: 21461001
    [No Abstract]   [Full Text] [Related]  

  • 4. Staphylococcal scalded skin syndrome in the course of lupus nephritis.
    Rydzewska-Rosołowska A; Brzosko S; Borawski J; Myśliwiec M
    Nephrology (Carlton); 2008 Jun; 13(3):265-6. PubMed ID: 18315709
    [No Abstract]   [Full Text] [Related]  

  • 5. Innovative management of lupus erythematosus.
    Knott HM; Martínez JD
    Dermatol Clin; 2010 Jul; 28(3):489-99. PubMed ID: 20510759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of systemic lupus erythematosus in a patient with hypoparathyroidism: a case report and review of the literature.
    Sahebari M; Afkhamizadeh M; Hashemzadeh K; Pezeshki Rad M
    Int J Rheum Dis; 2010 May; 13(2):175-9. PubMed ID: 20536604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Three cases of bullous lupus erythematosus].
    Jira M; Elqatni M; Sekkach Y; Elomri N; Mekouar F; Ghafir D
    Ann Dermatol Venereol; 2013 Dec; 140(12):778-83. PubMed ID: 24315223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of nephritis in systemic lupus erythematodes].
    Ligtenberg G; Derksen RH; Berden JH
    Ned Tijdschr Geneeskd; 1996 Sep; 140(39):1941-4. PubMed ID: 8927179
    [No Abstract]   [Full Text] [Related]  

  • 9. Overwhelming septic cavernous sinus thrombosis in a woman after combination of high-dose steroid and intravenous cyclophosphamide therapy for lupus nephritis.
    Chen YC; Cheng TT; Lai HM; Wu CH
    Lupus; 2000; 9(1):78-9. PubMed ID: 10713653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of membranous lupus nephritis: where are we now?
    Beck LH; Salant DJ
    J Am Soc Nephrol; 2009 Apr; 20(4):690-1. PubMed ID: 19279123
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine (CsA) in lupus nephritis: assessing the evidence.
    Moroni G; Doria A; Ponticelli C
    Nephrol Dial Transplant; 2009 Jan; 24(1):15-20. PubMed ID: 18852191
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus.
    Lavalle-Graef A; Villegas-Acosta L; Lavalle C
    Arch Med Res; 2004; 35(5):421-7. PubMed ID: 15610913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in treatment of systemic lupus erythematosus].
    Wang Q; Zhang X
    Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):161-4. PubMed ID: 23751573
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulse steroids: how much is enough?
    Franchin G; Diamond B
    Autoimmun Rev; 2006 Feb; 5(2):111-3. PubMed ID: 16431338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis.
    Ann Intern Med; 2015 Jan; 162(1):I24. PubMed ID: 25383607
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents.
    Vasquez S; Kavanaugh AF; Schneider NR; Wacholtz MC; Lipsky PE
    J Rheumatol; 1992 Oct; 19(10):1625-7. PubMed ID: 1464880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis.
    Boletis JN; Ioannidis JP; Boki KA; Moutsopoulos HM
    Lancet; 1999 Aug; 354(9178):569-70. PubMed ID: 10470708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pincer nail in a lupus patient.
    Azevedo THV; Neiva CLS; Consoli RV; Couto ACD; Dias AFMP; Souza EJR
    Lupus; 2017 Dec; 26(14):1562-1563. PubMed ID: 28420048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide therapy of severe lupus nephritis.
    Appel GB
    Am J Kidney Dis; 1997 Dec; 30(6):872-6; discussion 876-8. PubMed ID: 9398136
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylprednisolone in systemic lupus erythematosus.
    Howe HS; Boey ML; Feng PH
    Singapore Med J; 1990 Feb; 31(1):18-21. PubMed ID: 2333537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.